Fusheng Pharmaceutical., Ltd (Fusheng) develops botanical medicine for cancer, produce quality botanical extracts and supplements, and offers contract manufacturing for pharmaceutical, nutraceutical and nutritional industries. We have successfully launched the first Ginsenoside Rg3 (Rg3) anti-cancer drug (Shenyi capsule) in China in 2000.
We are the leading supplier of Rg3.

The company is located in Dalian Development Zone, China. Our state-of-art facilities include a 4,000 sp. m. (43,057sp.ft.) R&D center and a 6,000 sp. m. (64, 585 sp. ft.) cGMP certified manufacturing plant.